Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock
Reuters
"VRX short sellers were profitable every year after Bill Ackman's entry into the stock, eventually earning a 343.45% return on their average short position of $801 million," the firm said in a note to clients.
You'll recall that Bill Ackman started buying Valeant stock after collaborating with the company on a failed hostile takeover of Allergan. Months later, in March of 2015, Ackman started investing in Valeant, which at the time cost around $140.
It would climb to a high of $257 that summer before plummeting over 90% to where it sits today at $11.
Short sellers were there every step of the way. Jim Chanos, founder of Kynikos Associates, announced that he was short the company in 2014, saying that it was a rollup - company with no organic growth that required acquisitions to survive.
Another short seller, Andrew Left, contributed to Valeant's precipitous fall in October of 2015 by publishing a report calling into question whether or not Valeant was the next Enron.
More from S3:
Short sellers may start exiting their positions with Pershing Square's stock sales already having pushed VRX's stock price to year-to-date lows. But they might be waiting for the other shoe to drop, with the possibility that John Paulson, of Paulson & Co, will sell his 19.4 million share stake in VRX after Bill Ackman's recent exit. With short interest at $572 million, and falling, each $1 drop in VRX's stock price equates to approximately $50 million in profit.
That considered, now might be time to take some off the table.
Or you might take into consideration that despite the fact that even though Valeant beat Wall Street's expectations in its most recent earnings announcement, the stock fell 6% because guidance was weak. The company is looking to refinance its $30 billion in debt and needs to sell assets to make payments, and analysts worry that those sales could cut into the company's revenue.
So maybe you leave it on the table.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Catan adds climate change to the latest edition of the world-famous board game
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- JNK India IPO allotment – How to check allotment, GMP, listing date and more
- Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market